Our commitment is to serve the clinical needs of the health care provider with cutting-edge laboratory medicine by utilizing proven methodologies that are accurate and reliable. By working with experienced clinicians and opinion leaders throughout multiple medical disciplines we are able to build assays that are clinically relevant and provide actionable results.
Our highly experienced scientists have developed over 500 assays in their careers. They are empowered to validate every analyte and use the best methodology available to be sure the results you receive are accurate and precise. Our production team adheres to the strictest standards with an emphasis on quality and a realization that every sample belongs to a patient. Our customer service and technical support teams are dedicated to helping patients, clinicians and their staff understand our testing and the process of working with Diagnostic Solutions Laboratory in a seamless manner.
The GI-MAP™ (GI-Microbial Assay Plus) Stool Test
The GI-MAP™ (GI-Microbial Assay Plus) stool test utilizes cutting edge, FDA-approved technology to provide a true DNA/PCR based stool analysis which provides actionable information to the clinician regarding the microbiota and how it relates to many inflammatory, autoimmune, metabolic, cardiovascular, and other chronic diseases. This technology has high sensitivity, specificity and a rapid turnaround.
Using the same molecular technology, we have developed assays for microbes that are useful for integrative and function medicine practitioners. And unlike previous PCR assays, we have fully validated each target organism in our panel, so that you can have confidence in the results. The panel includes opportunistic organisms, normal flora, parasites, and fungi. DNA/PCR techniques also allow for the measurement of antibiotic resistance genes and virulence factors that contribute to pathogenicity. Both are used to help determine clinical significance and the most effective treatments.
In the last few decades, DNA analysis has transformed the field of microbiology. Almost all research of microbes utilize DNA methodology. The NIH has followed suit with initiatives including the Human Microbiome Project, which characterized the microbiome of 15 habitats of the body using DNA analysis. More than ever before, we are keenly aware of the health benefits or disease risks brought about by the microorganisms that inhabit the human body. Culture techniques, previously the standard, left up to 50% of bacterial species virtually invisible. Because most of the bacteria of the GI tract are anaerobes, culture based methods cannot cultivate them which leaves a large blind spot for clinicians when trying to diagnose the source of infection.
The GI-MAP (GI Microbial Assay Plus) stool test utilizes cutting edge, FDA approved technology to provide a true DNA/PCR based stool test. This technology has high sensitivity, specificity and a rapid turnaround. The GI pathogens include bacteria, parasites and viruses. Continuing with this platform, the GI-MAP measures opportunistic organisms, normal flora, fungi, parasites and antibiotic resistance genes. And the Plus refers to immunologic markers for GI health and function including SIgA, Elastase, Lactoferrin and Anti-gliadin testing.
- True DNA/PCR assay
- TAT- results in 10-14 days
- FDA Approved pathogen testing
- High sensitivity and specificity
- Antibiotic Resistance Genes
- Virulence Factors